databaseNapos

Acute Porphyria Drugs

A16AX03 - Sodium Phenylbutyrate
Probably Not Porphyrinogenic
PNP
Rationale
Sodium phenylbutyrate does not affect the activity of cytochrome P450 enzymes.
Metabolism and pharmacokinetics
Similar drugs
Explore alternative drugs in similar therapeutic classes
  • A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
  • A16AX Various Alimentary Tract and Metabolism Products
References
Tradenames
Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps Pheburane Ammonaps · Pheburane · Sodium phenylbutyrate Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Pheburane Pheburane Ammonaps Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙